Breast Cancer in Men Not Caught Early
Posted on: Tuesday, 8 July 2008, 00:00 CDT
Men, who make up about 1 percent of breast cancer cases, are often not treated until the disease has spread, Italian researchers said.
Dr. Marina Garassino of the Orion Collaborative Group conducted a retrospective analysis of 146 men with invasive breast cancer who were diagnosed between 1990 and 2007 across the 12 institutions in the ORION collaborative group.
The researchers found the disease often had already reached an advanced stage when the men were diagnosed.
All the men underwent surgery to remove their cancer. After surgery, 48 received radiotherapy and 100 received adjuvant chemotherapy or hormone therapy.
After a median follow-up of 5.2 years, the estimated 10-year disease-free survival rates were 80 percent for men with the earliest stages of disease and 44 percent for those with the largest tumors.
What is important for people to know is that most of the patients in our study had a delay in their diagnosis due to the fact that a mass in their breast was misunderstood, Garassino said in a statement. Therefore it is important that every mass in a man's breast must immediately be considered suspicious.
The findings were presented at a conference organized by the European Society for Medical Oncology in Lugano, Switzerland.
Source: United Press International
Related Articles
- Breast Disease to Breast Cancer
- When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer
- New Noninvasive Pap Test for Breast May Identify Breast Disease Up to Eight Years Earlier
- Guide aims to help men understand prostate cancer
- The Prostate Cancer Foundation Releasing First-Ever Guide for Men With Prostate Cancer and Their Families
- CORRECTED-Benign breast disease, history studied
- Benign breast disease, family history studied
- Benign Breast Disease an Important Breast Cancer Risk Factor
- Loving Partners Help Men Battle Prostate Cancer
- Symbollon Initiates Phase III Fibrocystic Breast Disease Pivotal Clinical Trial for IoGen; Company To Build Upon Successful Phase II Study As Patient Enrollment Begins in January
 |
 |
User Comments (0)
RSS Feeds